Lantheus Holdings, Inc. (LNTH)
75.89
-0.21
(-0.28%)
USD |
NASDAQ |
Apr 06, 16:00
75.93
+0.04
(+0.05%)
After-Hours: 20:00
Lantheus Holdings SG&A Expense (TTM) : 453.81M for Dec. 31, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Anika Therapeutics, Inc. | 49.09M |
| BioCryst Pharmaceuticals, Inc. | 348.65M |
| Iovance Biotherapeutics, Inc. | 152.58M |
| Plus Therapeutics, Inc. | 12.13M |
| BioStem Technologies, Inc. | 116.97M |